Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments

Cited by (401)

Items 101–200 of 401

1. Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
   Katharina Staufer, Rudolf E Stauber · 2023 · Biomedicines
2. KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
   Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young‐Joo Jin, Seung‐seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim et al. · 2024 · Clinical and Molecular Hepatology
3. Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross‐sectional study using transient elastography
   D. J. Harman, Stephen D. Ryder, Martin Wynn James, Emilie Wilkes, Tim R Card, Guruprasad Padur Aithal, Indra Neil Guha · 2017 · Alimentary Pharmacology & Therapeutics
4. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study
   Loek P. Smits, Bram F. Coolen, Maria D. Panno, Jurgen Henk Runge, W.H. Nijhof, Joanne Verheij, Max Nieuwdorp, Jaap Stoker, Ulrich H. Beuers, Aart Johannes Nederveen et al. · 2015 · Radiology
5. Clinical relevance of liver histopathology and different histological classifications of NASH in adults
   Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez‐Pinto, Giovanni Targher, Amedeo Lonardo · 2017 · Expert Review of Gastroenterology & Hepatology
6. Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
   Giulia Angelini, Simona Panunzi, Lidia Castagneto‐Gissey, Francesca Pellicanò, Andrea De Gaetano, Maurizio Pompili, Laura Riccardi, Matteo Garcovich, Marco Raffaelli, Luigi Ciccoritti et al. · 2022 · Gut
7. MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease
   Djuro Μacut, Ivana Božić Antić, Jelica Bjekić-Macut, Κωνσταντίνος Τζιόμαλος · 2017 · European Journal of Endocrinology
8. Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients
   Mohammad Shadab Siddiqui, Michael O. Idowu, Katharine A. Stromberg, Adam P. Sima, Emily Lee, Samarth Siddharth Patel, Sophia Ghaus, Carolyn J. Driscoll, Richard K. Sterling, Binu V. John et al. · 2020 · Clinical Gastroenterology and Hepatology
9. Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis
   Sumeet K. Asrani · 2015 · Clinical Gastroenterology and Hepatology
10. Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response
    Natsuko Kobayashi, Hiroko Iijima, Toshifumi Tada, Takashi Kumada, Masahiro Yoshida, Tomoko Aoki, Takashi Nishimura, Chikage Nakano, Ryo Takata, Kazunori Yoh et al. · 2018 · European Journal of Gastroenterology & Hepatology
11. Non-invasive tests of non-alcoholic fatty liver disease
    Guanlin Li, Xinrong Zhang, Huapeng Lin, Lilian Yan Liang, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong · 2022 · Chinese Medical Journal
12. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort
    Kento Imajo, Louise Ann Tetlow, Andrea Dennis, Elizabeth Shumbayawonda, Sofia Mouchti, Timothy James Kendall, Eve Fryer, Shogi Yamanaka, Yasushi Honda, Takaomi Kessoku et al. · 2021 · World Journal of Gastroenterology
13. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations
    Marco A. Arrese, Francisco Barrera M., Nicolás Triantafilo, Juan Pablo Arab · 2019 · Expert Review of Gastroenterology & Hepatology
14. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Haofei Hu, Yong Yun Han, Changchun Cao, Yongcheng He · 2022 · Journal of Translational Medicine
15. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease
    Sander Lefere, Frederique Van de Velde, Lindsey Devisscher, Marlies Bekaert, Sarah Raevens, Xavier Verhelst, Yves Van Nieuwenhove, Marleen M. Praet, Anne Hoorens, Christophe Van Steenkiste et al. · 2017 · International Journal of Obesity
16. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease
    Umut Emre Aykut, Ümit Akyüz, Atakan Yeşıl, Fatih Eren, Fatma Gerin, Rabia Ergelen, Çiğdem Çelikel, Yusuf Nadir Yilmaz · 2014 · Scandinavian Journal of Gastroenterology
17. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease
    Hirohito Takeuchi, Katsutoshi Sugimoto, Hisashi Oshiro, Kunio Iwatsuka, Shin Kono, Yu Yoshimasu, Yoshitaka Kasai, Yoshihiro Furuichi, Kentaro Sakamaki, Takao Itoi · 2017 · Journal of Medical Ultrasonics
18. Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis
    Shotaro Naganawa, Kenichiro Enooku, Ryosuke Tateishi, Hiroyuki Akai, Koichiro Yasaka, Junji Shibahara, Tetsuo Ushiku, Osamu Abe, Kuni Ohtomo, Shigeru Kiryu · 2018 · European Radiology
19. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
    Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad · 2021 · Biomedicines
20. Heteros tis eimi: On the Language of Menander's Young Lovers
    Frederick E. Brenk · 1987 · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
21. Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease
    Vaishali A. Patel, Arun Jayant Sanyal, Richard K. Sterling · 2016 · Clinics in Liver Disease
22. Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis
    Pauline L. M. Verhaegh, Roisin Bavalia, Björn Winkens, Ad Masclee, Daisy M.A.E. Jonkers, Ger H. Koek · 2017 · Clinical Gastroenterology and Hepatology
23. Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non‐alcoholic fatty liver disease
    Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Kento Imajo, Masato Yoneda, Miwa Kawanaka, Hiroyuki Kirikoshi, Masafumi Ono, Masataka Taguri et al. · 2018 · Journal of Gastroenterology and Hepatology
24. MACK‐3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non‐alcoholic steatohepatitis
    Kee Huat Chuah, Wan Nur Illyana Wan Yusoff, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Wah‐Kheong Chan · 2019 · Liver International
25. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study
    Claudia R.L. Cardoso, Cristiane Alves Villela‐Nogueira, Nathalie Carvalho Leite, Gil Fernando Salles · 2021 · Cardiovascular Diabetology
26. Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Daryl Ramai, Antonio Facciorusso, Erika Vigandt, Bryan Schaf, Waleed Saadedeen, Aditya Chauhan, Sara di Nunzio, Aashni Shah, Luca Giacomelli, Rodolfo Sacco · 2021 · Cells
27. Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study
    Karel Dvořák, Jan Stritesky, J Petrtýl, Libor Vı́tek, Renata Šroubková, Martin Lenicek A, Vaclav Smid, Martin Haluzı́k, Radan Brůha · 2014 · PLoS ONE
28. Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
    Rocío Gallego‐Durán, P. Cerro-Salido, Emilio Gómez-González, María Jesús Pareja, Javier Ampuero, María Carmen Rico, Rafael Aznar, Eduardo Vilar‐Gómez, Elisabetta Bugianesi, Javier Crespo et al. · 2016 · Scientific Reports
29. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
    Do Seon Song, U I. Chang, Sung Goo Kang, Sang-Wook Song, Jin Mo Yang · 2019 · Gut and Liver
30. Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non‐invasive tests for the diagnosis of advanced liver fibrosis in patients with non‐alcoholic fatty liver disease
    Chika Inadomi, Hirokazu Takahashi, Yuji Ogawa, Satoshi Oeda, Kento Imajo, Yoshihito Kubotsu, Kenichi Tanaka, Takaomi Kessoku, Michiaki Okada, Hiroshi Isoda et al. · 2020 · Hepatology Research
31. Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness
    Chow, Jeremy Chak‐Lun, Wong, Grace Lai‐Hung, Chan, Anthony Wing‐Hung, Shu, Sally She‐Ting, Chan, Carmen Ka‐Man, Leung, Julie Ka‐Yu, Choi, Paul Cheung‐Lung, Chim, Angel Mei‐Ling, Chan, Henry Lik‐Yuen, Wong, Vincent Wai‐Sun · 2019 · Journal of Gastroenterology and Hepatology
32. Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients
    Daniella Braz Parente, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Lilian Machado‐Silva, Fátima Aparecida Ferreira Figueiredo, Valéria Pereira Lanzoni, Carlos Frederico Ferreira Campos, Pedro Emmanuel Alvarenga Americano do Brasil, Marília Brito Gomes, Renata de Mello Perez et al. · 2015 · PLoS ONE
33. Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis
    Xingxiang Yang, Xiao-Xia Geng, Ren-Gang Huang, Jian-Mei Lin, Nan Jiang · 2016 · Saudi Journal of Gastroenterology
34. IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD – a pilot study
    Hannes Hagström, Per I Stal, Rolf W. Hultcrantz, Kerstin Brismar, Ishrath Ansurudeen · 2017 · Scandinavian Journal of Gastroenterology
35. Recent advances in understanding and managing non-alcoholic fatty liver disease
    Somaya A. M. Albhaisi, Arun Jayant Sanyal · 2018 · F1000Research
36. Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease
    Luca Miele, Maria Assunta Zocco, Fabrizio Pizzolante, Nicoletta De Matthaeis, Maria Elena Ainora, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Gianludovico Rapaccini · 2020 · Metabolism
37. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
    Saleh A. Alqahtani, Pegah Golabi, James M. Paik, Brian P Lam, Amir H. Moazzez, Hazem A. Elariny, Zachary D Goodman, Zobair M. Younossi · 2021 · Obesity Surgery
38. Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.
    Stacey S. Brener · 2015 · Europe PMC (PubMed Central)
39. A Machine Learning Based Framework to Identify and Classify Non-alcoholic Fatty Liver Disease in a Large-Scale Population
    Weidong Ji, Mingyue Xue, Yushan Zhang, Hua Yao, Yushan Wang · 2022 · Frontiers in Public Health
40. Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease.
    Jiao-Ya Xu, Zhong-Ping Li, Li Zhang, Guang Ji · 2014 · World Journal of Gastroenterology
41. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis
    Jia-Zhen Zhang, Jingjing Cai, Yao Yu, Zhi‐Gang She, Hongliang Li · 2019 · Gene Expression
42. Screening for nonalcoholic fatty liver disease-when, who and how?
    Christoph G. Dietrich, Monika Rau, Andreas Geier · 2021 · World Journal of Gastroenterology
43. Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy‐proven Japanese non‐alcoholic fatty liver disease patients
    Takanori Ito, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Kazuhiko Hayashi, Daisaku Nishimura, Hidenori Toyoda, Takashi Kumada, Hidemi Goto et al. · 2018 · Journal of Gastroenterology and Hepatology
44. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease
    Zhenghui Gordon Jiang, Elliot B. Tapper, Margery A. Connelly, Carolina Frade Magalhães Girardin Pimentel, Linda Feldbrügge, Mi-Sung Kim, Sarah A. Krawczyk, Nezam H. Afdhal, Simon Christopher Robson, Mark A. Herman et al. · 2016 · Liver International
45. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD)
    Ma Ai Thanda Han, Rola Saouaf, Walid S. Ayoub, Tsuyoshi Todo, Edward Mena, Mazen Noureddin · 2017 · Expert Review of Clinical Pharmacology
46. Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Cristiane Valle Tovo, Cristiane Alves Villela‐Nogueira, Nathalie Carvalho Leite, Carine L. Panke, Gabriela Z. Port, Sabrina Alves Fernandes, Caroline Buss, Gabriela Perdomo Coral, Ana Carolina Cardoso, Claudia M. Cravo et al. · 2019 · Annals of Hepatology
47. Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C
    Kentaro Matsuura, Nobuhiro Aizawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hidenori Toyoda, Takashi Kumada, Etsuko Iio, Kyoko Ito, Shintaro Ogawa, Masanori Isogawa et al. · 2018 · Open Forum Infectious Diseases
48. Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
    Yen‐Ying Chen, Matthew M. Yeh · 2020 · Journal of the Formosan Medical Association
49. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease
    Benedikt K. Kaufmann, Nick Seyfried, Daniel Hartmann, Phillipp Hartmann · 2023 · American Journal of Physiology-Gastrointestinal and Liver Physiology
50. Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic Health
    Kristin M. Hirahatake, Richard S. Bruno, Bradley W. Bolling, Christopher N. Blesso, Lacy M. Alexander, Sean H. Adams · 2019 · Advances in Nutrition
51. The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLD
    Maya Balakrishnan, Rohit Seth Loomba · 2019 · Journal of Clinical Gastroenterology
52. Discordant pathological diagnosis of non‐alcoholic fatty liver disease: A prospective multicenter study
    Takuya Kuwashiro, Hirokazu Takahashi, Hideyuki Hyogo, Yuji Ogawa, Kento Imajo, Masato Yoneda, Takashi Nakahara, Satoshi Oeda, Kenichi Tanaka, Yuichiro Amano et al. · 2019 · JGH Open
53. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis
    Shengliang Xin, Qiao Zhan, Xiaofan Chen, Jinghang Xu, Yanyan Yu · 2020 · BMC Gastroenterology
54. Development and validation of a neural network for NAFLD diagnosis
    Paolo Sorino, Angelo Campanella, Caterina Bonfiglio, Antonella Mirizzi, Isabella Franco, Antonella Bianco, Maria Gabriella Caruso, Giovanni Misciagna, Laura Rosana Aballay, Claudia Buongiorno et al. · 2021 · Scientific Reports
55. Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
    Young Eun Chon, Young‐Joo Jin, Jihyun An, Hee Yeon Kim, Miyoung Choi, Dae Won Jun, Mi Na Kim, Ji Won Han, Han Ah Lee, Jung Hwan Yu et al. · 2024 · Clinical and Molecular Hepatology
56. Accurate non-invasive detection of MASH with fibrosis F2-F3 using a lightweight machine learning model with minimal clinical and metabolomic variables
    Konstantinos Stefanakis, Geltrude Mingrone, Jacob George, Christos Socrates Mantzoros · 2024 · Metabolism
57. Systematic review and meta‐analysis: non‐invasive detection of non‐alcoholic fatty liver disease related fibrosis in the obese
    Geraldine Ooi, S. Mgaieth, Guy D. Eslick, Paul Robert Burton, William W. Kemp, Stuart Keith Roberts, Wendy A. Brown · 2017 · Obesity Reviews
58. Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease
    Toshihide Shima, Kyoko Sakai, Hirohisa Oya, Takayuki Katayama, Yasuhide Mitsumoto, Masayuki Mizuno, Yoshihiro Kanbara, Takeshi Okanoue · 2019 · Journal of Gastroenterology
59. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease
    Ajay Kumar. Duseja, Shivaram Prasad Singh, Manu Mehta, S. Shalimar, Jayanthi Venkataraman, Varun Mehta, Krishnadas Devadas, Sanjib K. Kar, Omesh Goyal, Aabha S. Nagral et al. · 2022 · Metabolic Syndrome and Related Disorders
60. Magnetic resonance elastography (MRE) in assessing hepatic fibrosis: performance in a cohort of patients with histological data
    Mashal Jatoi Batheja, Hugo E. Vargas, Annelise M. Silva, F. Blake Walker, Yu-Hui H. Chang, Giovanni De Petris, Alvin C. Silva · 2014 · Abdominal Imaging
61. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients
    Samar Kamal Darweesh, Rasha Abdelaziz, Dina Abdelfatah, Naglaa A. AbdElazim, Shaimaa A. Fathi, Dina Ismail Attia, Mohamed AbdAllah · 2019 · European Journal of Gastroenterology & Hepatology
62. Liver stiffness measurement using acoustic radiation force impulse elastography in overweight and obese patients
    Dina Ismail Attia, Heike Bantel, Henrike Lenzen, Michael Peter Manns, M Gebel, Andrej Potthoff · 2016 · Alimentary Pharmacology & Therapeutics
63. Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH)
    Jiayu Wu, Ruinan Zhang, Feng Shen, Rui‐Xu Yang, Da Zhou, Haixia Cao, Guangyu Chen, Qin Pan, Jian‐Gao Fan · 2018 · Medical Science Monitor
64. Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non‐alcoholic fatty liver disease
    Yasushi Honda, Kento Imajo, Takashi Kobayashi, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Masato Yoneda, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima · 2019 · Hepatology Research
65. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease
    Wen‐Yue Liu, Kenneth I. Zheng, Xiao‐Yan Pan, Hong‐Lei Ma, Pei‐Wu Zhu, Xixi Wu, Rafael S. Rios, Giovanni Targher, Christopher D. Byrne, Xiao‐Dong Wang et al. · 2019 · Journal of Gastroenterology and Hepatology
66. Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with non‐alcoholic fatty liver: An external validation study
    Ramy Younes, Chiara Rosso, Salvatore Petta, Monica Cucco, Milena Marietti, Gian Paolo Caviglia, Alessia Ciancio, Maria Lorena Abate, Carlo Cammà, Antonina Smedile et al. · 2017 · Liver International
67. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity
    Geraldine Ooi, Arul Earnest, William W. Kemp, Paul Robert Burton, Cheryl Laurie, Ammar Majeed, Nathan Anthony Johnson, Catriona McLean, Stuart Keith Roberts, Wendy A. Brown · 2018 · International Journal of Obesity
68. Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
    Sampath De Silva, Wenhao Li, Polychronis Kemos, James Hallimond Brindley, Jibran Mecci, Salma Samsuddin, Joanne Chin‐Aleong, Roger M. Feakins, Graham R. Foster, Wing‐Kin Syn et al. · 2017 · Frontline Gastroenterology
69. Recomendaciones para la detección, diagnóstico y seguimiento de los pacientes con enfermedad por hígado graso no alcohólico en atención primaria y hospitalaria
    Llorenç Caballería, Salvador Augustín, Teresa Broquetas, Rosa Maria Morillas, Mercedes Vergara, Silvia Virolés, Ma Rosario Hernández, Isabel Serra, Albert Goday, Lluís Vila et al. · 2019 · Medicina Clínica
70. Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease
    Young‐Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, In Hee Kim, Soo Yeon Lee, Baek‐hui Kim, Jeong Woo Kim et al. · 2020 · Clinical and Translational Gastroenterology
71. Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
    Nuria Barbarroja, M. Ruiz-Ponce, Laura Cuesta-López, Carlos Pérez-Sánchez, Chary López-Pedrera, I. Arias de la Rosa, Eduardo Collantes‐Estévez · 2022 · Frontiers in Immunology
72. Low‐fasting triglyceride levels are associated with non‐invasive markers of advanced liver fibrosis among adults in the United States
    Zhenghui Gordon Jiang, Yusuke Tsugawa, Elliot B. Tapper, Michelle Lai, Nezam H. Afdhal, Simon Christopher Robson, Kenneth Jay Mukamal · 2015 · Alimentary Pharmacology & Therapeutics
73. Application of Ultrasound Elastography for Chronic Allograft Dysfunction in Kidney Transplantation
    Zijie Wang, Haiwei Yang, Chuanjian Suo, Jifu Wei, Ruoyun Tan, Min Gu · 2017 · Journal of Ultrasound in Medicine
74. Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German society of gastroenterology, digestive and metabolic diseases (DGVS)–April 2022–AWMF Registration No.: 021–025
    Authors, Collaborators: · 2022 · Zeitschrift für Gastroenterologie
75. Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials
    Wong, Vincent Wai-Sun, Tak, Won Young, Goh, George Boon Bee, Cheng, Pin-Nan, Lawitz, Eric J., Younossi, Zobair M., Vuppalanchi, Raj, Younes, Ziad, Alkhouri, Naim, Wang, Lulu et al. · 2023 · Clinical Gastroenterology and Hepatology
76. Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis
    Chiara Rosso, Gian Paolo Caviglia, Maria Lorena Abate, Ester Vanni, Lavinia Mezzabotta, Giovanni Antonio Touscoz, Antonella Olivero, Andrea Marengo, Mario Rizzetto, Elisabetta Bugianesi et al. · 2015 · Digestive and Liver Disease
77. Advances in ultrasound elastography for nonalcoholic fatty liver disease
    Masato Yoneda, Yasushi Honda, Asako Nogami, Kento Imajo, Atsushi Nakajima · 2020 · Journal of Medical Ultrasonics
78. A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery
    Shirley Yuk‐Wah Liu, Vincent Wai‐Sun Wong, Simon Kin‐Hung Wong, Grace Lai‐Hung Wong, Carol Man‐Sze Lai, Candice Chuen‐Hing Lam, Sally She‐Ting Shu, Henry Lik‐Yuen Chan, Enders K. Ng · 2021 · Scientific Reports
79. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
    Atul Goyale, A. Jain, Colette J Smith, Μargarita Papatheodoridi, Marta Guerrero Misas, Davide Roccarina, Laura Iogna Prat, Dimitri P. Mikhailidis, Devaki R. Nair, Emmanuel A. Tsochatzis · 2021 · PLoS ONE
80. NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials
    Tripti Khare, Karina Liu, Lindiwe Oslee Chilambe, Sharad Khare · 2025 · International Journal of Molecular Sciences
81. Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio‐T2 DM cohort study
    Nathalie Carvalho Leite, Cristiane Alves Villela‐Nogueira, Marcel T. Ferreira, Claudia R.L. Cardoso, Gil Fernando Salles · 2015 · Liver International
82. Exploring Biomarkers in Nonalcoholic Fatty Liver Disease Among Individuals With Type 2 Diabetes Mellitus
    Fariba Ahmadizar, Zobair M. Younossi · 2024 · Journal of Clinical Gastroenterology
83. Ultrasound-based liver elastography in the assessment of fibrosis
    Cheng Fang, Adrian K.P. Lim, Paul Singh Sidhu · 2020 · Clinical Radiology
84. Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpoint
    Jiayun M. Fang, Jerome Cheng, Michael F. Chang, Joseph C. Ahn, Maria A. Westerhoff · 2021 · Modern Pathology
85. The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
    Jose Hernandez Roman, Mohammad Shadab Siddiqui · 2020 · Endocrinology Diabetes & Metabolism
86. HFpEF and MASLD: converging mechanisms and clinical implications
    Federico Capone, Steffen P. Häseli, Luo Liu, Stefano Strocchi, Claudia Langenberg, Aldons Jake Lusis, Maik Pietzner, Deborah M. Muoio, Oliver J. Rider, Betty Raman et al. · 2026 · Nature Reviews Cardiology
87. Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non‐alcoholic fatty liver disease
    Akira Okajima, Yoshio Sumida, Hiroyoshi Taketani, Tasuku Hara, Yuya Seko, Hiroshi Ishiba, Takeshi Nishimura, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi et al. · 2016 · Hepatology Research
88. New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease
    Toshifumi Tada, Takashi Kumada, Hidenori Toyoda, Toshiji Saibara, Masafumi Ono, Masayoshi Kage · 2018 · Biomarkers
89. Non-alcoholic fatty liver disease–a chronic disease of the 21st century
    Peter P. Metrakos, Nilsson Tommy · 2017 · Journal of Biomedical Research
90. Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
    Huai Zhang, Rafael S. Rios, Jérôme Boursier, Rodolphe Anty, Wah‐Kheong Chan, Jacob George, Yusuf Nadir Yilmaz, Vincent Wai‐Sun Wong, Jian‐Gao Fan, Jean‐François Dufour et al. · 2023 · Chinese Medical Journal
91. Longitudinal Magnetic Resonance Imaging with ROS‐Responsive Bilirubin Nanoparticles Enables Monitoring of Nonalcoholic Steatohepatitis Progression to Cirrhosis
    Wonsik Jung, Muhammad Asaduddin, Hyeongseop Keum, Youngju Son, Dohyun Yoo, Do Hyeon Kim, Seojung Lee, Dong Yun Lee, Jin Roh, Sung‐Hong Park et al. · 2024 · Advanced Materials
92. NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?
    Shivaram Prasad Singh, Rakesh Kumar Barik · 2019 · Journal of Clinical and Experimental Hepatology
93. Accuracy of non‐invasive scoring systems for diagnosing non‐alcoholic steatohepatitis‐related fibrosis: Multicenter validation study
    Yoshito Itoh, Yuya Seko, Toshihide Shima, Tomoaki Nakajima, Kei Mizuno, Yusuke Kawamura, Norio Akuta, Kiyoaki Ito, Miwa Kawanaka, Akira Hiramatsu et al. · 2018 · Hepatology Research
94. Hígado graso no alcohólico: una pandemia poco conocida
    Salvador Augustín, Isabel Graupera, Juan Caballería · 2017 · Medicina Clínica
95. The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial
    Zohreh Sadat Sangsefidi‬, Mahdieh Hosseinzadeh, Ali Mohammad Ranjbar, Mohsen Akhondi‐Meybodi, Hossein Fallahzadeh, Hassan Mozaffari–Khosravi · 2019 · Nutrition Journal
96. Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease
    Toshifumi Tada, Toshiji Saibara, Masafumi Ono, Hirokazu Takahashi, Yuichiro Eguchi, Hideyuki Hyogo, Miwa Kawanaka, Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda et al. · 2021 · European Journal of Gastroenterology & Hepatology
97. Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
    Jincheng Wang, Tao Qin, Jin-Yu Sun, Shiwu Li, Lihua Cao, Xiaojie Lu · 2022 · Frontiers in Physiology
98. Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan®)
    Monica Lupșor‐Platon · 2015 · World Journal of Gastroenterology
99. Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
    Leon Anton Adams, Wah‐Kheong Chan · 2020 · Seminars in Liver Disease
100. An Assessment of the Feasibility, Patient Acceptance, and Performance of Point-of-Care Transient Elastography for Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta-Analysis
     Taranika Sarkar Das, Xucong Meng, Mohamed Abdallah, Mohammad Bilal, Raiya Sarwar, Aasma Shaukat · 2024 · Diagnostics